Wird geladen...
Low-frequency KRAS mutations are prevalent in lung adenocarcinomas
AIM: This study quantified low-frequency KRAS mutations in normal lung and lung adenocarcinomas, to understand their potential significance in the development of acquired resistance to EGFR-targeted therapies. MATERIALS & METHODS: Allele-specific Competitive Blocker-PCR was used to quantify KRAS...
Gespeichert in:
| Veröffentlicht in: | Per Med |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5084916/ https://ncbi.nlm.nih.gov/pubmed/27795727 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/pme.14.69 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|